Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial
2012-12-11
(Press-News.org) An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American Society of Hematology annual meeting.
The combination of two immunosuppressive compounds -- tacrolimus plus sirolimus -- did not provide a statistically significant, GVHD-free survival benefit over the long-used standard of care, tacrolimus plus methotrexate, said researchers from Dana-Farber Cancer Institute who led the multi-center trial.
However, there were some "upsides" of the tacrolimus/sirolimus treatment that could prove advantageous for certain patients, said Corey Cutler, MD, MPH, first author of the report. Among them: patients engrafted slightly more rapidly and suffered much less from mucositis, a common and painful side-effect that causes sores in the mouth and throat.
But there were also "downsides," Cutler said – an increased incidence of veno-occlusive disease (blood clots in the liver) and a slight increase in the rate of late-onset GVHD.
"We were a little disappointed in the results, but excited to offer an alternative to the standard of care for the past 25 years," said Cutler, who, along with Joseph Antin, MD, of Dana-Farber, senior author of the report, had led clinical studies of sirolimus beginning in 2000 in hopes that it would promote better survival from GVHD than the standard treatment.
The phase 3 randomized controlled trial was carried out by the Bone and Marrow Clinical Trials Network (BMT CTN) at 26 centers. It enrolled over 300 patients, the majority of whom had acute leukemia in remission. The patients had received stem cell transplants from a matched sibling donor.
The primary endpoint of 114-day acute GVHD-free survival was 67 percent in the tacrolimus/sirolimus group and 62 percent in the tacrolimus/methotrexate group – a difference that was not statistically significant. At two years after transplantation, there was no difference in disease-free survival and overall survival.
"This study establishes this regimen as an alternative to the standard of care – it could be preferable in certain scenarios," Cutler said. "It will continue to be the standard of care at Dana-Farber"
INFORMATION:
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center and it provides pediatric care with Boston Children's Hospital as Dana-Farber/Children's Hospital Cancer Center. Dana-Farber is the top ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding. Follow Dana-Farber on Facebook: www.facebook.com/danafarbercancerinstitute and on Twitter: @danafarber.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-12-11
Public opinion on environmental issues such as climate change, deforestation, and toxic waste seems to fall along increasingly partisan lines. But new research suggests that environmental messages framed in terms of conservative morals — describing environmental stewardship in terms of fending off threats to the "purity" and "sanctity" of Earth and our bodies — may help to narrow the partisan gap.
A study from researchers at UC Berkeley has found that while people who identified themselves as conservatives tend to be less concerned about the environment than their liberal ...
2012-12-11
COLUMBIA, Mo. – Medication reconciliation is a safety practice in which health care professionals review patients' medication regimens when patients transition between settings to reduce the likelihood of adverse drug effects. It is among the most complex clinical tasks required of physicians, nurses and pharmacists, who must work cooperatively to minimize discrepancies and inappropriate medication orders. Now, a University of Missouri gerontologiccal nursing expert suggests that acknowledging practitioners' varying perspectives on the purpose of medication reconciliation ...
2012-12-11
ATLANTA - A two-prong approach combining ibrutinib and rituximab (Rituxin®) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with minor side effects in a Phase 2 clinical trial at the University of Texas MD Anderson Cancer Center.
Researchers presented the results today at the 54th annual meeting of the American Society of Hematology (ASH).
"This is a patient population with a great need for more targeted therapies," said Jan Burger, M.D., Ph.D., associate professor in MD Anderson's Department of Leukemia. Burger was lead author of ...
2012-12-11
Physicians associated with "patient philanthropy" – financial donations from grateful patients to a medical institution – are concerned with how these contributions might affect their own behavior and attitudes, and how they might impact the doctor-patient relationship. A new study¹ by Scott Wright, MD and Joseph A. Carrese, MD, MPH of Johns Hopkins University, and colleagues, explores this topic. The paper considers the perspectives of internal medicine physicians working in an academic medical center who have had experiences with these situations. Their findings appear ...
2012-12-11
OAK BROOK, Ill. – Some stroke patients may benefit from cerebral angioplasty and stent placement, according to a new study published online in the journal Radiology.
"As many as 70 percent of ischemic stroke patients could have positive clinical outcomes with the additional use of intra-arterial revascularization using stents," said Martin Roubec, M.D., Ph.D., a neurologist in the Comprehensive Stroke Center at the University Hospital Ostrava in the Czech Republic.
Ischemic stroke, the most common form of stroke, occurs when blockage in an artery—often from a blood ...
2012-12-11
OAK BROOK, Ill. – A combination of diagnostic tests, including imaging and cerebrospinal fluid biomarkers can improve prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease, according to a new study published online in the journal Radiology.
"Because new treatments are likely to be most effective at the earliest stages of Alzheimer's disease, there is great urgency to develop sensitive markers that facilitate detection and monitoring of early brain changes in individuals at risk," said Jeffrey R. Petrella, M.D., associate professor of radiology, ...
2012-12-11
DURHAM, N.C. -- Employing a combination of imaging and biomarker tests improves the ability of doctors to predict Alzheimer's in patients with mild cognitive impairment, according to researchers at Duke Medicine.
The findings, which appear Tuesday, Dec. 11, 2012, in the journal Radiology, provide new insight into how to accurately detect Alzheimer's before the full onset of the disease.
Duke researchers studied three tests – magnetic resonance imaging (MRI), fluorine 18 fluorodeoxyglucose positron emission tomography (FDG-PET), and cerebrospinal fluid analysis – to ...
2012-12-11
San Diego, CA, December 11, 2012 – The average American child from age 8 to 18 watches about 4.5 hours of TV each day. Seventy percent have a TV in the bedroom and about one-third of youth aged 6-19 is considered obese. Previous studies have shown that TV viewing time during childhood and adolescence continues into adulthood, resulting in overweight and elevated total cholesterol. An investigative team from the Pennington Biomedical Research Center in Baton Rouge, LA reports new study findings, establishing the relationship between having and watching TV in the bedroom ...
2012-12-11
The SARS epidemic of 2002-2003 was short-lived, but a novel type of human coronavirus that is alarming public health authorities can infect cells from humans and bats alike, a fact that could make the animals a continuing source of infection, according to a study to be published in in mBio®, the online open-access journal of the American Society for Microbiology, on December 11. The new coronavirus, called hCoV-EMC, is blamed for five deaths and several other cases of severe disease originating in countries in the Middle East. According to the new results, hCoV-EMC uses ...
2012-12-11
One common idea about why there are fewer women professors in the sciences than men is that women are less willing to work the long hours needed to succeed. Writing in the January Issue of BioScience, Shelley Adamo of Dalhousie University, Nova Scotia, Canada, rejects this argument. She points out that women physicians work longer hours than most scientists, under arguably more stressful conditions, but that this does not deter women from entering medicine.
Why, then, do women leave the academic track in biology at higher rates than they leave the medical profession? ...
LAST 30 PRESS RELEASES:
[Press-News.org] Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial
